Skip to main content

T65.854A vs T65.854D

T65.854A (Toxic effect of medetomidine, undetermined, initial encounter) compared with T65.854D (Toxic effect of medetomidine, undetermined, subsequent encounter), from the official CMS tabular data. T65.854A and T65.854D code the same injury at a different phase of treatment.

Relationship

Review

Encounter relationship

T65.854A
Initial encounter
Toxic effect of medetomidine, undetermined, initial encounter
T65.854D
Subsequent encounter
Toxic effect of medetomidine, undetermined, subsequent encounter

Same underlying diagnosis, different encounter phase.

The 7th character records the phase of care for the encounter being coded, so a single encounter takes one of these characters, not several. Review whether both phases belong on the same episode of care.

Source: ICD-10-CM Official Guidelines, Section I.C.19.a

Can these codes be reported together?

Same injury, other encounter phase. T65.854A and T65.854D code the same injury at a different phase of treatment, set by the 7th character.

The 7th character records the type of care given at the encounter being coded (ICD-10-CM Official Guidelines, Section I.C.19.a), so one encounter takes one of these, not both.

Side by side

T65.854AToxic effect of medetomidine, undetermined, initial encounterT65.854DToxic effect of medetomidine, undetermined, subsequent encounter
Billing statusBillableBillable
ClassificationS00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88)S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88)
7th characterThe appropriate 7th character is to be added to each code from category T65The appropriate 7th character is to be added to each code from category T65
Use additional code
code to identify associated manifestations, such as:
bradycardia NOS (R00.1)
somnolence, stupor and coma (R40.-)
code to identify associated manifestations, such as:
bradycardia NOS (R00.1)
somnolence, stupor and coma (R40.-)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources